.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Combination glaucoma agents produce good control of IOP

March 1, 2002

Cincinnati, OH-The IOP-lowering effect of dorzolamide HCl/timolol maleate (Cosopt, Merck, West Point, PA) is comparable to that of brimonidine tartrate (Alphagan, Allergan, Irvine, CA) and timolol maleate after 6 months of treatment.